Stock TLIS TALIS BIOMEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 02:00:00 29/06/2024 am IST 		5-day change 1st Jan Change
8.662 USD +0.54% Intraday chart for Talis Biomedical Corporation -2.24% +16.27%
08/05 Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02/04 North American Morning Briefing : Stocks Seen -2- DJ

Business Summary

Talis Biomedical Corporation is a molecular diagnostic company. The Company is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.

Number of employees: 99

Sales per Business

USD in Million2022Weight2023Weight Delta
Grant
80.7 %
1 24.1 % 2 80.7 % +48.45%
Antigen Tests Products
19.3 %
4 75.9 % 0 19.3 % -88.72%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
5 100.0 % 2 100.0 % -55.65%

Managers

Managers TitleAgeSince
Robert Kelley CEO
 Chief Executive Officer 52 01/20/01
Rebecca Markovich DFI
 Director of Finance/CFO 51 01/22/01
Kim Popovits BRD
 Director/Board Member 65 31/20/31
Emily Faucette IRC
 Investor Relations Contact - 01/21/01
Gillian Green
- -
Matthew Pepe HRO
 Human Resources Officer - 01/21/01
Jill Green LAW
 General Counsel - 01/20/01

Members of the board

Members of the board TitleAgeSince
Matthew Posard BRD
 Director/Board Member 56 01/16/01
Randal Scott BRD
 Director/Board Member 66 01/14/01
Kim Popovits BRD
 Director/Board Member 65 31/20/31
Robert Kelley CEO
 Chief Executive Officer 52 01/20/01
Heiner Dreismann BRD
 Director/Board Member 69 19/23/19
Rustem Ismagilov FOU
 Founder 50 26/13/26
Raymond Cheong BRD
 Director/Board Member 42 01/20/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,822,153 1,670,797 ( 91.69 %) 0 91.69 %
Stock B 0 29,863,674 0 0

Shareholders

NameEquities%Valuation
Baker Bros. Advisors LP
27.90 %
508,323 27.90 % 5 M $
DME Capital Management LP
8.180 %
149,052 8.180 % 1 M $
Randal Scott
6.305 %
114,884 6.305 % 1 M $
BML Capital Management LLC
2.346 %
42,743 2.346 % 393 236 $
Vanguard Group, Inc. (Subfiler)
1.702 %
31,013 1.702 % 285 320 $
Rustem Ismagilov
0.9720 %
17,712 0.9720 % 162 950 $
Susquehanna Securities LLC
0.9566 %
17,431 0.9566 % 160 365 $
Prelude Capital Management LLC
0.8193 %
14,928 0.8193 % 137 338 $
Kim Popovits
0.7604 %
13,855 0.7604 % 127 466 $
Geode Capital Management LLC
0.6525 %
11,890 0.6525 % 109 388 $
NameEquities%Valuation
Baker Bros. Advisors LP
100.00 %
1,990,914 100.00 % 18 M $

Company contact information

Talis Biomedical Corp.

1375 West Fulton Market Suite 700

60607, Chicago

+

http://www.talis.bio
address Talis Biomedical Corporation(TLIS)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
TALIS BIOMEDICAL CORPORATION Stock Talis Biomedical Corporation
+16.27% 1.58Cr
MODERNA, INC. Stock Moderna, Inc.
+19.41% 4.55TCr
LONZA GROUP AG Stock Lonza Group AG
+38.65% 3.94TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.62% 3.85TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+26.95% 3.07TCr
CELLTRION, INC. Stock Celltrion, Inc.
-13.50% 2.6TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.74% 2.59TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+44.87% 1.41TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+34.36% 1.27TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-7.14% 1.13TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. TLIS Stock
  4. Company Talis Biomedical Corporation